Prognostic value of tumor–stroma ratio combined with the immune status of tumors in invasive breast carcinoma

Abstract

Determination of TSR is a simple, fast and cheap method. The effect on RFP of TSR when combined with immune status of tumors or expression of classical HLA class I is even stronger. Both are promising for further prediction and achievement of tailored treatment for breast cancer patients.